I notice that MEI Pharma's 1 Year target has been raised from $12 to $16 - check the Yahoo MEI Pharma message board summary page. I don't know if this means much but an ungrade is better than a downgrade.
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint